Neuromuscular Blockade: Outcome and Recovery for Laparoscopic Bariatric Surgery
Neuromuscular Blockade as a Determinant of Surgical Outcome and Post-operative Recovery, in Patients Undergoing Elective Laparoscopic Bariatric Surgery
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The aim of the current observational study is to better assess the relationships between neuromuscular blockade and multiple surgical outcomes in patients undergoing elective laparoscopic bariatric surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2014
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 20, 2014
CompletedFirst Posted
Study publicly available on registry
November 24, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedAugust 19, 2015
August 1, 2015
2 months
November 20, 2014
August 18, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
surgeon evaluation of working surgical conditions
the surgeon will score the surgical working conditions at 15 min intervals, according to a 5-point ordinal scale
intraoperative
Interventions
Laparoscopic sleeve gastrectomy (LSG) is a restrictive procedure which consists in creating a narrow tube-like stomach, designed to decrease appetite by reducing the ability of the stomach to distend.
Eligibility Criteria
MO patients from the bariatric surgery department of Hopital Sacre Coeur de Montreal
You may qualify if:
- MO patients \[body mass index (BMI)≤ 55kg/m2\] scheduled for elective laparoscopic sleeve gastrectomy under general anesthesia.
You may not qualify if:
- a physical status \>3 (ASA),
- a difficult tracheal intubation,
- a known or suspected disorder affecting NMB,
- a renal, pulmonary, cardiac, and/or hepatic dysfunction,
- malignant hyperthermia,
- pregnancy, breastfeeding,
- allergy or contraindication to narcotics, rocuronium, neostigmine, or other medications used during anesthesia
- patients with sleep apnea syndrome will also be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Raeder J. Bariatric procedures as day/short stay surgery: is it possible and reasonable? Curr Opin Anaesthesiol. 2007 Dec;20(6):508-12. doi: 10.1097/ACO.0b013e3282f09443.
PMID: 17989541RESULTServin F. Ambulatory anesthesia for the obese patient. Curr Opin Anaesthesiol. 2006 Dec;19(6):597-9. doi: 10.1097/ACO.0b013e328010cb78.
PMID: 17093361RESULTMurphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008 Jul;107(1):130-7. doi: 10.1213/ane.0b013e31816d1268.
PMID: 18635478RESULTButterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010 Sep;105(3):304-9. doi: 10.1093/bja/aeq157. Epub 2010 Jun 24.
PMID: 20576632RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Y Garneau, MD
Hopital Sacre Coeur de Montreal
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, General Surgery Department
Study Record Dates
First Submitted
November 20, 2014
First Posted
November 24, 2014
Study Start
September 1, 2014
Primary Completion
November 1, 2014
Study Completion
December 1, 2014
Last Updated
August 19, 2015
Record last verified: 2015-08